These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11784295)

  • 1. Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes.
    Erickson S; Matikainen S; Thyrell L; Sangfelt O; Julkunen I; Einhorn S; Grandér D
    Eur J Biochem; 2002 Jan; 269(1):29-37. PubMed ID: 11784295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatases.
    Zhang H; Conrad DM; Butler JJ; Zhao C; Blay J; Hoskin DW
    J Immunol; 2004 Jul; 173(2):932-44. PubMed ID: 15240680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells.
    Castro A; Sengupta TK; Ruiz DC; Yang E; Ivashkiv LB
    J Immunol; 1999 Feb; 162(3):1261-9. PubMed ID: 9973378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
    J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells.
    Matikainen S; Sareneva T; Ronni T; Lehtonen A; Koskinen PJ; Julkunen I
    Blood; 1999 Mar; 93(6):1980-91. PubMed ID: 10068671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
    Bianchi M; Meng C; Ivashkiv LB
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9573-8. PubMed ID: 10920190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
    Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine.
    Wasik MA; Nowak I; Zhang Q; Shaw LM
    Leuk Lymphoma; 1998 Feb; 28(5-6):551-60. PubMed ID: 9613985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
    J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
    Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
    J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
    Bright JJ; Kerr LD; Sriram S
    J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet radiation inhibits interleukin-2-induced tyrosine phosphorylation and the activation of STAT5 in T lymphocytes.
    Kulms D; Schwarz T
    J Biol Chem; 2001 Apr; 276(16):12849-55. PubMed ID: 11278301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligation of RARgamma inhibits proliferation of phytohaemagglutinin-stimulated T-cells via down-regulating JAK3 protein levels.
    Ludányi K; Nagy ZS; Alexa M; Reichert U; Michel S; Fésüs L; Szondy Z
    Immunol Lett; 2005 Apr; 98(1):103-13. PubMed ID: 15790515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
    Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
    J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-modulation of IL-2-triggered JAK3-STAT5 signaling following CD4-ligand binding.
    Lowry RP; Goebel J
    Transplant Proc; 1999; 31(1-2):820-1. PubMed ID: 10083356
    [No Abstract]   [Full Text] [Related]  

  • 18. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
    J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules.
    Chida D; Wakao H; Yoshimura A; Miyajima A
    Mol Endocrinol; 1998 Nov; 12(11):1792-806. PubMed ID: 9817603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.
    Rocha-Zavaleta L; Huitron C; Cacéres-Cortés JR; Alvarado-Moreno JA; Valle-Mendiola A; Soto-Cruz I; Weiss-Steider B; Rangel-Corona R
    Cell Signal; 2004 Nov; 16(11):1239-47. PubMed ID: 15337523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.